Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lisa M. Bernard
Observed names:
L Bernard,
L M Bernard,
L. Bernard,
L. M. Bernard,
L.M. Bernard,
Lisa Bernard,
Lisa M Bernard
show all 7
Observed institutions:
Western University,
University of St Andrews,
Cornerstone Research Group (United States),
St Joseph's Health Care,
St. Joseph’s Healthcare Hamilton,
McMaster University
show all 6
OpenAlex ID:
A5005048822
Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD
2015
·
Leena Patel
, Lisa M. Bernard
, et al.
·
Clinical Journal of the American Society of Nephrology
·
169
Cost-Effectiveness Analysis of Therapies for Chronic Kidney Disease Patients on Dialysis
2012
·
Daniel T. Grima
, Lisa M. Bernard
, et al.
·
PharmacoEconomics
·
49
A Canadian Physician Survey of Dyspepsia Management
1998
·
Naoki Chiba
, Lisa Bernard
, et al.
·
Canadian Journal of Gastroenterology
·
45
PDF
Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
2013
·
A D Sung
, D T Grima
, et al.
·
Bone Marrow Transplantation
·
36
A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation
2014
·
H. L. Cameron
, L. M. Bernard
, et al.
·
Journal of Medical Economics
·
33
PDF
An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
2004
·
Heather McDonald
, Margaret Hux
, et al.
·
PubMed
·
33
Lack of Increased Colonization with Vancomycin-Resistant Enterococci during Preferential Use of Vancomycin for Treatment during an Outbreak of Healthcare-Associated Clostridium difficile Infection
2010
·
Mark Miller
, Lisa Bernard
, et al.
·
Infection Control and Hospital Epidemiology
·
28
Cost-Effectiveness of Oxaliplatin in the Adjuvant Treatment of Colon Cancer in Canada
2010
·
C. L. Attard
, J. A. Maroun
, et al.
·
Current Oncology
·
28
PDF
Cost-effectiveness to tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: A Canadian perspective
2001
·
Bernie J. O'Brien
, Ron Goeree
, et al.
·
Clinical Therapeutics
·
28
Clinical and Economic Impacts of Latanoprost 0.005% in First-Line Treatment of Open-Angle Glaucoma and Ocular Hypertension in France
2003
·
L.M. Bernard
, R. Althin
, et al.
·
European Journal of Ophthalmology
·
27
A modeled economic evaluation of sevelamer for treatment of hyperphosphatemia associated with chronic kidney disease among patients on dialysis in the United Kingdom
2012
·
Lisa Bernard
, David Mendelssohn
, et al.
·
Journal of Medical Economics
·
21
PDF
Economic evaluation of sevelamer for the treatment of hyperphosphatemia in chronic kidney disease patients not on dialysis in the United Kingdom
2013
·
Melissa Thompson
, Susan Bartko-Winters
, et al.
·
Journal of Medical Economics
·
19
PDF
Elective Laparoscopic Paraesophageal Hernia Repair Leads to an Increase in Life Expectancy Over Watchful Waiting in Asymptomatic Patients
2023
·
Steven R. DeMeester
, Lisa Bernard
, et al.
·
Annals of Surgery
·
17
Intraocular pressure control and persistence on treatment in glaucoma and ocular hypertension
2005
·
David Tingey
, Lisa M. Bernard
, et al.
·
Canadian Journal of Ophthalmology
·
15
Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,
2011
·
Nelson J. Chao
, Daniel T Grima
, et al.
·
Blood
·
8
Updated Markov Model to Determine Optimal Management Strategy for Patients with Paraesophageal Hernia and Symptoms, Cameron Ulcer, or Comorbid Conditions
2024
·
Steven R DeMeester
, Lisa Bernard
, et al.
·
Journal of the American College of Surgeons
·
7
A Canadian Economic Analysis of U.S. Oncology Adjuvant Trial 9735
2011
·
Lisa Bernard
, S. Verma
, et al.
·
Current Oncology
·
6
PDF
Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysis
2012
·
Daniel T. Grima
, Elizabeth S. Dunn
, et al.
·
Current Medical Research and Opinion
·
3
Considerations in Developing Model-based Economic Evaluations of Glaucoma Treatment
2006
·
Rikard Althin
, Daniel T. Grima
, et al.
·
Journal of Glaucoma
·
3
TCT-566 Cost-Effectiveness Of The Xience™ Cobalt Chromium Everolimus Eluting Stent Compared With Bare Metal Stents: A United States Payer Perspective
2015
·
Nicole Ferko
, Giuseppe Ferrante
, et al.
·
Journal of the American College of Cardiology
·
1
PDF
Real-World Cost Effectiveness Of The Mitraclip For The Treatment Of High-Risk Mitral Regurgitation
2014
·
A.W. Asgar
, P. Khairy
, et al.
·
Value in Health
·
1
PDF
The Authors’ Reply to van Baal et al.: “Pharmacoeconomic Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al.”
2013
·
Daniel T. Grima
, Lisa M. Bernard
, et al.
·
PharmacoEconomics
·
1
Puk14 Challenges in Assessing Cost-effectiveness of Therapies for Dialysis Patients: a Case Study of Sevelamer for the Treatment of Hyperphosphatemia
2010
·
D Grima
, D Mendelssohn
, et al.
·
Value in Health
·
1
PDF
Docetaxel plus cyclophosphamide is cost-effective compared to doxorubicin plus cyclophosphamide, based on an economic analysis of US oncology trial 9735: additional rationale to avoid anthracyclines in the adjuvant treatment of operable breast cancer?.
2009
·
S Verma
, N Mittmann
, et al.
·
Cancer Research
·
1
Pae11 Economic Evaluation of Latanoprost as First Line Glaucoma Therapy in 6 European Countries
2003
·
S Aballéa
, M Martin
, et al.
·
Value in Health
·
1
PDF
Show more works
View as search
Works count:
31
Citation count:
581
H-index:
14
I10-index:
14
Year
Topic
Type
